The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition

The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
Kalorama Information’s latest edition of our in vitro diagnostic market report is available for sales. This represents the fourteenth time in two decades our analysts have fully assessed the in vitro diagnostic market from scratch and re-report numbers. Last year, the COVID-19 pandemic highlighted how important testing is in a way that could not be imagined. This year, COVID-19 is to some degree a routine test category in respiratory and infectious disease testing, themselves high-growth segments. Now the question will be how increased back to work/back to school/back to physician office plans will affect IVD markets? This as well as the segment-specific testing market trends will be addressed in this volume.

What is the Size of the IVD Market in 2021?

The market for in vitro diagnostics, instruments and reagents exceeds 117 billion dollars. It is made up of many testing segments, totaled in this report.

Beyond COVID-19, Tests for cancer and infectious disease detection, transplant success, pharmaceutical selection have added healthcare value and improved outcomes. Genetic tests for rare diseases and prenatal assessment are increasingly utilized. Tests for emerging diseases have also become increasingly important.

Kalorama Information’s estimates stand out from others because the firm is a focused publisher of in vitro diagnostics market research and not an entity publishing reports on all topics. Months of analysis ad review of secondary sources by seasoned analysts, critical readings of current and historic company filings and releases, interviews with relevant experts and searching of government sources and journal literature result in reliable global market modeling, trusted by many of the top companies in the market.

But in vitro diagnostics represents a large market, with scores of significant competitors. Sorting out the marketplace can be difficult without a definitive guide. What is the market size for clinical chemistry, immunoassays, molecular tests, hematology tests and other test categories?

What is the Size of IVD Market Segments? Who’s Winning? Who’s Merged? Who’s Launched Game-Changing Products?

One book definitively answers these questions, from a publisher that is focused on in vitro diagnostics. Now in its 14th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. For two decades, the 1,500-plus page report has provided reliable estimates and real-world forecasts for the in vitro diagnostics industry.

Comprehensive Market Coverage

As part of its offering, this report includes:

  • COVID-19 Testing Markets, Current and Projected.
  • Impact on Other IVD Test Markets, 2020 and 2021
  • 1500 + Page Report Based on Vendor Reporting, Interviews, Vendor Activities
  • Authored by Veteran IVD Analysts with Industry Knowledge
  • 12 Detailed Market Chapters with 2021 Market Estimates
  • Where is IVD Heading? – Market Segment Projections to 2026
  • Regional Breakouts Including Country IVD Markets
  • Sections on China and The United States IVD Markets
  • Coverage of Growth Markets: Eastern Europe and the Middle East, and Southeast Asia
  • Superior Company Profiles of Top Tier Companies and Hundreds of Smaller Concerns
  • Industry-Standard Business Planning Tools
  • Coverage of Trends and Market Estimates for Essential IVD Segments
The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2026 for defined segments of the IVD market and various sub-segments, including:
  • COVID Testing – Immunoassays and Molecular
  • Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal)
  • Clinical Chemistry and “Core Lab” Markets
  • Point-of-Care Testing (POC) (Professional and Self-Testing)
  • Glucose Testing
  • Substance Abuse Testing
  • Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases – DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
  • Blood Banking
  • Pap, ISH, IHC, HPV and Other Tissue-Based Tests
  • Infectious Disease Immunoassay Testing
  • Hematology
  • Cardiac Markers, Tumor Markers, Diabetes/hbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs
  • Coagulation Tests
  • Quality Control
For each of the listed in vitro diagnostics market segments, 2021 in vitro diagnostics market size, 2026 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers’ product innovations. The market data is put into a context with real-world industry and medical practice trends.


The Worldwide Market for In Vitro Diagnostic Tests has been called “The Bible of the IVD Industry” by customers, which include top IVD firms. Using Kalorama Information’s The Worldwide Market for In vitro Diagnostic (IVD) Tests, 14th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.

Country-Level Coverage

The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 14th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:
  • US
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Netherlands
  • Turkey
  • Poland
  • Canada
  • China
  • Japan
  • Malaysia
  • Singapore
  • South Korea
  • Australia
  • Saudi Arabia
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • South Africa
  • Eastern Europe
  • Emerging Markets
  • Rest of World
The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2021.

Competitive Analysis and Corporate Profiling

The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies. First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report. Companies profiled include:
  • A. Menarini Diagnostics
  • Abbott Diagnostics
  • Arkray
  • Becton, Dickinson (BD)
  • Beckman Coulter
  • bioMerieux
  • Bio-Rad
  • Bruker
  • Cepheid
  • Danaher
  • DiaSorin
  • Eiken Chemical
  • Fujirebio
  • Grifols
  • Hologic
  • Illumina
  • Instrumentation Laboratory
  • Lab Corp.
  • Leica Biosystems
  • Nova Biomedical
  • Meridian Bioscience, Inc.
  • Mindray
  • Perkin Elmer
  • Qiagen
  • Quest
  • Quidel
  • Radiometer
  • Randox
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher Scientific
  • Werfen


  • Executive Summary
    • Table The Worldwide IVD Market, 2021 and 2026 ($billions)
    • Significant Gains in IVD Segments, 2020-2021
      • Table Year Over Year Growth in IVD Market by Segment
    • Scope and Methodology
      • Table Exchange Rate Fluctuations, 2016-2020
    • Size and Growth of the Market
      • Table Global In Vitro Diagnostic Sales by Product Market, 2021-2026 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry) and COVID-19 Dx 2021
    • Differences Between the 13th and 14th Edition
    • A Note on Growth Rates
    • COVID-19 Market Value
      • Table COVID-19 Test Revenue Breakout (Molecular, POC, Immunoassay)
    • IVD Market Highlights
    • What to Watch Long-Term
      • The Newer Emerging Markets
        • Table Emerging Country Markets by Projected IVD Market Growth, 2021-2026
      • At Home Testing: COVID -19 Trend or Here to Stay?
      • Collaborations Between IVDs
      • Synthetic Biology and Diagnostics
  • Introduction
    • IVD Landscape
    • Report Design
      • Reporting Changes for Segments from the 13th Edition
    • The Challenge of PAMA
    • Market Analysis of IVD Market Segments
      • Table Global In Vitro Diagnostic Sales by Product Market, 2021-2026 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry) and COVID-19 Dx 2021
      • Table Developed vs. Developing IVD Market Shares, 2021 and projected 2026 (%)
    • Top Suppliers and Niche Players
      • Introduction
      • Overview of the Top Tier Companies
        • Table Clinical Diagnostic Revenues of Selected Top IVD Companies, 2020 and estimated 2021 ($ million)
      • Overview of Selected Second Tier Companies
        • Table Revenues of Selected Niche Players, 2020- and estimated 2021 ($ million, estimated)
    • The Impact of COVID for the Top Tier Companies
      • Table Top Tier Market Distribution, 2020 and 2021, estimated (%)
    • IVD Companies Mergers & Acquisitions
      • Table Selected IVD Mergers and Acquisitions 2016-2021 (first half)
    • Collaboration, Partnership, Alliance Agreements
      • Table Selected IVD Partnerships/Collaborations/Alliance Agreements 2016-2019
    • Test Services
      • Table Selected Test Services, Sales 2016-2020 ($ millions, estimated where applicable)
      • Table Global Lab Market Segmentation, 2020 ($ billions)
      • Table Revenues for a Selection of U.S.-based Reference Labs, 2016-2020 ($ million, estimated)
    • Historical IVD Market vs Today
      • In the Beginning to Now
        • Table Share of IVD Market by Segment, Percentage, 2000 and 2021 Compared (Clinical Chemistry, Hematology, Coagulation, Immunoassays, Microbiology (ID/AST), POC Diabetes, POC - Other, Histology/Cytology, Molecular, Blood Banking [imm & typing], Others)
      • Future
    • Point of View
      • Table IVD Market by Segment, 2019 Compared to 2021
    • COVID-19 Impact and Summary
      • Table Top and Second Tier Combined Performance in COVID-19 and Non-COVID-19 IVD Market Segments, Q1-Q4 2020 and Q1-Q2 2021, estimated Q3-Q4 2021
      • COVID-19 Market Value
        • Table COVID-19 Market Estimates by Segment (Immunoassay, Molecular, Rapid - POC), 2021 ($ millions)
        • Table IVD COVID-19 Market, Distribution by Region (North America, Europe, Asia Pacific, RoW), 2021%
  • The Global Picture for In Vitro Diagnostic Markets
    • Background
      • Simultaneous Threats: Chronic and Acute
      • Expected World IVD Market Developments
    • Global Population and Aging
      • Table Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
      • Workforce Reduction
        • Table Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World) 2020
      • Addressing the Aging Trend
    • WHO Essential IVD List
      • Table Diseases Addressed by WHO Model List of Essential In Vitro Diagnostics (EDL)
      • Increase in Chronic Diseases
        • Table Leading Causes of Death Globally
    • COVID-19
      • Table Individual EUAs for Molecular Tests for SARS-CoV-2
      • Table Authorized Molecular-Based Laboratory Developed Tests for Detection of Nucleic Acid from SARS-CoV-2
      • Table Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2
      • Table Individual EUAs for Serology Tests for SARS-CoV-2
      • Table Individual EUAs For IVDs for Management of COVID-19 Patients
    • Emerging and Emerged Markets
      • Table Market Potential by Total Population, and Percent Urban 2020 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia)
    • Size and Forecast for the Global IVD Market
      • Table Global In Vitro Diagnostic Market; Major Country/Region Markets, 2021 and 2026 ($ millions) (United States, EU 15/W. Europe, Japan, China, Canada, India, Eastern Europe, Brazil, Colombia, Mexico, Saudi Arabia, Turkey, UAE, Malaysia, Russia, South Africa, South Korea, Australia, ROW)
      • Table Global In Vitro Diagnostic Market; Regional Markets, 2021 and 2026 ($ millions) (North America, Europe, Asia Pacific, Latin America, ROW)
      • COVID-19 Impact for 2021
        • Table Global In Vitro Diagnostic Market - YOY Growth 2020-2021
        • Table Global In Vitro Diagnostic Market; Regional Markets, 2020-2021 YOY Growth (North America, Europe, Asia Pacific, Latin America, ROW)
    • The IVD Market in the United States
      • Table United States IVD Market by Segment, 2021 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Clinical Sequencing, Nucleic Acid Assays, Coagulation, Histology, Hematology, Blood Grouping, Others)
      • PAMA and Reimbursement Changes
        • Table Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2025
      • LDT Oversight Update
      • Personalized Medicine and NGS
    • IVD Market in Europe: Growing Markets
      • Europe Industry Actions
        • Table Western European IVD Market by Country, 2021 ($ millions, estimated) (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden, Switzerland/Norway, UK)
      • EU Regulation
        • Table IVD Market Per Capita, Europe, 2020 Estimates (Switzerland, Germany, Netherlands, Sweden, France, Slovenia, United Kingdom, Italy, Spain, Slovakia, Greece, Croatia, , Czech Republic, Hungary, Poland, Romania, Bulgaria, Russia, Ukraine)
      • Personalized Medicine in Europe
      • Brexit
    • Eastern Europe: Growth Region
      • Table Eastern European IVD Market by Country, 2021 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine, Other)
      • Table Eastern Europe IVD Market by Country, 2021 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine)
    • Japan
      • Table Japan IVD Market by Segment, 2021 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
    • China: Current IVD Market
      • Table China IVD Market by Segment, 2021 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
      • Table Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
      • Clinical Laboratory Tests in China
      • Private Laboratories
      • Distribution in China
    • India: Population and Opportunity
      • Table India IVD Market by Segment, 2021 (%) (Clinical Chemistry, Hematology, Coagulation; Microbiology; POC Diabetes; POC Other; Immunoassay; Histology; Others)
      • Labs in India
    • Rest of Asia
      • Table Asia Pacific IVD Market by Country, 2021 ($ millions) (Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam)
    • Brazil
      • Disease Trends
        • Table Brazil IVD Market by Broad Segment, 2021 (%) (Clinical Chemistry, Microbiology, POC Diabetes, POC Other, Immunoassay, Histology, Others)
    • Mexico
      • Table Mexico IVD Market by Broad Segment, 2021 (%) (Clinical Chemistry, Microbiology, POC, Immunoassay, Histology, Others)
    • The Russian Federation
    • Canada
    • Emerging Markets
      • Saudi Arabia IVD Market
      • South Africa IVD Market
      • Turkey IVD Market
      • Colombia IVD Market
      • United Arab Emirates (UAE) IVD Market
      • South Korea IVD Market
      • Other Markets to Watch
    • IVD Market Opportunity by Country
      • Table IVD Market Opportunity by Country (2021 Market Rank, Country CAGR 2021-2026) (China, Philippines, Brazil, Israel, Malaysia, India, Mexico, Indonesia, Chile, Poland, Saudi Arabia, South Korea, Romania, Colombia, United Arab Emirates, Argentina, Hungary, Vietnam, Iraq, Peru, Japan, France, Turkey, Egypt, Singapore, Luxembourg, Croatia, Jordan, U.S., Germany, United Kingdom, Canada, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Denmark, Ireland, Finland, Iran, Thailand, Venezuela, Italy, Australia, Portugal, Greece, Czech Republic, South Africa, Norway, Bulgaria, Slovakia, Slovenia)
      • Table IVD Market Opportunity by Country: Top 20 Markets (Country Market Value ($millions), Country CAGR 2021-2026) (United States, Japan, Germany, China, France, United Kingdom, Canada, Italy, Spain, Brazil, Australia, Russia, Netherlands, India, Switzerland, Turkey, Poland, Belgium, Sweden, Mexico)
  • Company and Industry Trends
    • Introduction
      • Advanced Medicine Without Borders
        • Table Key Emerging IVD Markets (Brazil, Russia, India, China, South Korea, Mexico, Turkey, Vietnam) 2016-2021 ($millions)
      • China Market Information
      • Clinical Genetic Test Advances
      • Direct to Consumer Genetic Test Services
      • Programs and Initiatives
        • Table Selected Genomic Test Innovations
      • Future Trends
    • Gene Editing
      • Table Selected Gene Editing / CRISPR Innovations
      • CRISPR as a Diagnostic Tool
      • Basic Research
      • Food Industry
      • Investor Interest
    • Microbiome
      • Table Selected Microbiome Test Innovations
    • Next Generation Sequencing
      • Table Selected Clinical NGS Platforms on the Market
    • Liquid Biopsy
      • Table Liquid Biopsy: Selected Liquid Biopsy Innovations
      • Quality Assurance
      • Product News
      • Market Cleared Products
      • For Research Use Only
      • Products in Development
      • Liquid Biopsy in Microbiology
      • Liquid Biopsy Companies in 2021
      • The Future for Liquid Biopsy
    • Information Technology Advances and Artificial Intelligence
      • AI in Clinical Practice
        • Table Selected AI Market Cleared Tests
      • The Regulatory Pathway
      • Product Initiatives
        • Table Selected AI Product Initiatives in Development and Collaborations
      • IBM Watson Health
      • AI in Liquid Biopsy
        • Table Selected AI/Liquid Biopsy Initiatives
      • Future Trends
    • Exosome Sequencing
      • Table Selected Exosome Test Innovations
    • Biotin Interference in Immunoassay Detection Errors
      • Table Biotin-free Offerings Currently on the Market
    • Traumatic Brain Injury and IVD
    • Telehealth
    • Blockchain
    • Substance Abuse
      • Opioid Epidemic
      • COVID-19 and Substance Abuse
      • Biomarkers and Substance Abuse
      • Clinical Laboratory Testing for Drugs of Abuse
        • Table Global Drug Abuse Statistics
      • Urine
      • Blood
      • Oral
      • Hair
        • Table Selected Opioid Test FDA Approvals, 2015-2021
    • Micro-hospital Opportunities
    • Climate Change and Infectious Disease
    • Kickback Schemes
    • Early Sepsis Detection
  • Point-of-Care Tests
    • Overview and Trends
    • Professional POC
      • Table Professional POC Test Sales by Category, Worldwide 2021 -2026 ($million) (Glucose, Critical Care POC, Fertility, Infectious Diseases, Cardiac Markers, Cholesterol, Coagulation, HbA1c POC, Hematology, Fecal Occult Blood, Drugs of Abuse, Others)
      • Table Selected Profession POC Test Innovations (excluding COVID-19 testing)
    • OTC Self Testing
      • Table POC Self-Test Sales by Category, Worldwide, 2021-2026($million) (Glucose, Self; Glucose, Continuous; Pregnancy; Coagulation; Fecal Occult Blood; Drugs of Abuse; H. pylori; HIV; Cholesterol; Urinalysis; Other [TSH, Allergy, Autoimmune, etc])
    • Pregnancy/Fertility Tests
      • Table POC Pregnancy and Fertility Test Market Distribution by End User, 2021(%) (OTC Professional)
      • Table Pregnancy/Fertility POC Test Sales Distribution by Global Region, 2021 (United States, Europe, Japan, RoW)
    • Colon Cancer Screening
      • Table Selected POC Colon Cancer Tests
      • Table Colon Cancer POC Test Sales Distribution by Global Region, 2021 (United States, Europe, Japan, RoW)
    • Lipid Testing
      • Table Lipid POC Test Sales Distribution by Global Region, 2021(United States, Europe, Japan, RoW)
    • Drugs of Abuse Testing
      • Table POC Drugs of Abuse Test Sales Distribution by Setting, 2021 (Employment Screening, Criminal Justice, Critical Care - Traditional POC)
      • Table Drugs of Abuse Tests on the Market
    • Rapid and POC Infectious Disease Testing
      • Table Innovations in Molecular POC Infectious Disease Diagnostics
      • Products
      • HIV and Hepatitis Testing and Monitoring
      • Tuberculosis
      • Tropical and Neglected Diseases
      • Respiratory Diseases
      • Sepsis and Nosocomial Disease
      • Sexual Health
      • Lyme Disease
        • Table Innovations in Molecular POC Infectious Disease Diagnostics
      • COVID-19
      • Market Size and Growth
        • Table Infectious Disease POC Test Demand by Type, 2021 (Influenza, HIV, STD, Hepatitis, Malaria, C.Difficile, E.coli, H.pylori, Home Test/OTC, Others)
        • Table Infectious Disease POC Test Sales Distribution by Global Region, 2021 (United States, Europe, Japan, RoW)
    • Diabetes Testing - Blood Glucose Monitoring
      • Table Glucose POC Test Sales Distribution by Global Region, 2021 (United States, Europe, Japan, RoW)
      • Table POC Glucose Testing Market Growth by Category, 2021-2026 CAGR (%) (Glucose OTC; Glucose Professional; Glucose, continuous; HbA1c POC)
      • IT to Aid Diabetes Management
        • Table Selected Apps and Glucose Management IT
      • Diabetes Market Analysis
        • Table Global Diabetes Sales by Test Category, 2021-2026 (Glucose, OTC; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; HbA1c, Lab) ($ millions)
      • POC Glucose Competitors
        • Table POC Test Revenues of Selected IVD Glucose Companies, 2021 ($ million, estimated)
      • Blood Glucose Self-Testing
        • Table Selected Glucose Self-Test Meter Innovations
      • Noninvasive Testing Devices
        • Table Selected Noninvasive Glucose Monitoring Devices
      • Continuous Glucose Monitoring
        • Table Selected Continuous Blood Glucose System Developments
      • Blood Glucose Testing by Professionals
        • Table Selected Innovations in Hospital-based Glucose Monitoring
      • Diabetes Testing - Glycated Hemoglobin
        • Table Global HbA1c Test Sales Market and Distribution by Setting, 2021-2026 ($ millions) (HbA1c POC, HbA1c Lab)
        • Table Selected POC HbA1c Devices
      • Genes and Other Markers of Diabetes
        • Table Selected POC Diabetes Monitoring Tests
    • The Major POC Test Players
      • Table POC Test Revenues of Selected IVD Companies, 2021 ($ million, estimated)
  • The Core Lab
    • Core Lab Overview and Trends
      • Table Selected Analytes for the Core Lab
    • Connectivity
    • Overview of Chemistry Tests
      • Lab Automation
    • Market Analysis
      • Table Global Clinical Chemistry Sales by Test Category, 2021-2026 ($millions) (General Chemistries, Blood Gases, Urinalysis)
      • Table Global Clinical Chemistry Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
      • Table Major Clinical Chemistry Companies (Blood gas/electrolyte, general chemistries, UA)
      • Table Selected Clinical Chemistry Innovations
      • Rapid Response Systems
        • Table Selected Major Whole Blood Chemistry Analyzers
      • Critical Care Analysis
        • Table Blood Gas, Electrolyte and Critical Care Instrument Market by End User, 2021 and 2026 (Labbased, POC-based)(in $ millions)
        • Table Blood Gas, Electrolyte, and Critical Care Market Leaders inc POC, 2021 (percent distribution of total sales)
      • User Apps
        • Table Selected Apps, Critical Care and Urinalysis IT Innovations
      • Urinalysis
        • Table UA Market by End User, 2021 and 2026 (Lab-based, POC-based)
        • Table Urinalysis Systems ( inc POC) Market Leaders, 2021 (percent distribution of total sales) est
        • Table Selected Urinalysis Innovations
    • The Commercial Outlook for Chemistry Tests
  • Immunoassays
    • Overview and Trends
      • Immunoassay Technology Continues to Evolve
        • Table Selected Immunoassay Technologies
      • Mass Spectrometry
        • Table Selected Innovation in Mass Spectrometry for Routine Analyses
      • Radioimmunoassays
    • Market Analysis
      • Leading Suppliers and Growth Potential
        • Table Global Lab-based Immunoassay (excluding infectious disease and blood screening) Sales, by Analyte Type, 2021-2026 ($millions) (Cardiac Markers, Tumor Markers, Autoimmune, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Total; w/o HbA1c)
        • Table Global Immunoassay (excluding infectious disease and blood screening) Sales Distribution by Region, 2021 (%) (North America, Europe, Japan, Asia Pacific, RoW)
        • Table IVD Quality Control Market (estimated), 2021 ($millions)
        • Table Selected Immunoassay Quality Control Products
        • Table 2021 Revenues of Leading Lab-based Immunoassay Vendors (in millions $), Estimated
    • Mature Assay Segment
      • Thyroid Function
      • Therapeutic Drug Monitoring
      • Anemia
      • Toxicology/DAU
      • Allergy
    • Maturing Immunoassays
      • Proteins
    • Growth Immunoassays
      • Vitamin D
        • Table Selected Vitamin D Immunoassays
      • Tumor Markers
        • Table Selected Tumor Marker Innovations
      • Cardiac Markers
        • Table Selected Cardiac Marker Innovations
      • Autoimmune
        • Table Selected Autoimmune Test Innovations
      • Rheumatoid Arthritis
        • Table Selected Arthritis Immunoassay Innovations
      • Gastrointestinal Disorders
        • Table Selected Inflammatory Bowel Disease Test Innovations
      • Transplant Management
        • Table Selected Immunoassays for Transplant Medicine
      • Women's Health
        • Table Selected Women's Health Innovations
      • Alzheimer's Disease
        • Table Selected Innovations for Alzheimer's Disease Immunoassays
      • Sleep Apnea
      • Miscellaneous
        • Table Selected Immunoassay Innovations
      • Point-of-Care OTC and Professional Use
        • Table Global POC Immunoassay Sales Distribution by Region, 2021 (United States, Europe, Japan, RoW)
        • Table Global POC Immunoassay Test Sales by Test Category, 2021-2026 (millions $) (OTC/Self Tests: Pregnancy/Ovulation, Drugs of Abuse, HIV, H. pylori, Infectious Disease/COVID-19, Other, OTC/Self Total; Professional POC: Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Infectious Disease/COVID-19, Other, Professional Total)
        • Table Selected Self-Test Immunoassay Innovations
      • Pregnancy Testing
      • Cardiovascular Diagnostics
      • Drugs of Abuse/Therapeutic Drug Monitoring
    • Innovating POC
      • Table Selected POC Test Innovations
      • Table Selected POC Immunoassay Test Platforms
    • The Commercial Outlook for Immunoassays
  • Molecular Assays
    • Overview
      • Table Common Next Generation Molecular Test Traits
    • Sample Preparation and Quality Control
      • Table Selected Molecular Test Sample Preparation and QC Innovations
    • Advanced Molecular Tests and Technologies
      • Exosome Sequencing
        • Table Selected Exosome Test Innovations
      • Liquid Biopsy
        • Table Selected Liquid Biopsy Innovations
      • Metabolomic Profiling
      • Information Technology
        • Table Selected IT Innovations in Molecular Diagnostics
      • Artificial Intelligence AI
      • Forensic Studies - An Emerging Opportunity
        • Table Selected Innovations in Forensic DNA Testing
      • Test Platforms
        • Table Key Molecular Technologies and Major Players
        • Table Selected Molecular Test Platform Innovations
    • Major Players
      • Table Molecular Test Revenues of Selected IVD Vendors, 2016-2021 (in millions $)
    • Market Analysis
      • Table Global Genomic, HLA and Oncology Molecular Test Sales by Type with NIPT 2021-2026 (in millions $)
      • Oncology
        • Table Global Molecular Cancer Test Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
        • Table Selected Molecular Tumor Marker Test Innovations
      • Inherited Diseases and Thrombophilia SNPs
        • Table Most Frequently Requested Genetic Tests
        • Table Global Molecular Thrombophilia Assay Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
        • Table Selected Genomic Tests for Inherited Diseases
      • Psychiatric Disorders
      • Prenatal and Newborn Testing
        • Table Global Prenatal Test Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
        • Table Prenatal Services Provided
        • Table Selected Molecular Tests for Prenatal Analysis
      • Transplant Diagnostics
        • Table Global Molecular HLA Testing Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
        • Table Selected Innovations of Molecular Transplant Diagnostics
    • The Commercial Outlook for Molecular Tests
  • Hematology
    • Overview of Hematology and Trends
      • Table Hematology Analyzer Distribution of Sales by Menu Capability, 2021 estimated
      • Table Lab-based Hematology Sales by Analyte Average Annual Distribution %
      • Digital Image Analysis
        • Table Selected Hematology Image Analysis Innovations, 2014-2021
      • Digital Evolution
      • Quality Control Measurement Programs
        • Table Selected Quality Control Hematology FDA Registrations, 2021
    • Laboratory-based Hematology Testing
      • Table Selected Hematology Innovations, 2014-2020
      • Table FDA Registration Distribution by Company for Hematology Analyzers/Instruments by %
      • Table Global Laboratory-based Hematology Test and Instrument Market, 2021 and 2026 ($ millions)
      • Regional Laboratory-based Hematology Test and Instrument Market
        • Table Global Laboratory-based Hematology Test and Instrument Market, by Region, 2021 (North America, Europe, Asia Pacific, RoW)
    • Decentralized Hematology Testing
      • Table POC-based Hematology Analyzer/Instrument FDA Approvals by Year, through 2020
      • Hemoglobin/Hematocrit at the POC
        • Table POC Hematology Distribution by Specialty (hematocrit/hemoglobin vs. other routine hematology (WBC, erythrocyte, platelet)
        • Table Selected POC Hemoglobin and Hematocrit Systems
        • Table Selected POC Hematology Analyzer Systems
        • Table Decentralized Hematology Test and Instrument Market, 2021 and 2026 ($ millions) (Instruments, lab-style; Handheld devices)
    • Market Analysis: Leading Suppliers
      • Table Top Hematology Company Revenues (laboratory and POC), 2021 ($ millions)
      • Table Global Hematology (Laboratory-based and POC) Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
    • The Commercial Outlook for Hematology Tests
  • Coagulation
    • Overview and Trends of Coagulation and Immunohematology Tests
    • Special Topics
      • COVID-19
      • Direct Oral Anticoagulants (DOACs)
        • Table Major Anticoagulants
      • D-dimer
        • Table Global D-dimer Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
    • Market Analysis
      • Table Global Coagulation Sales by Segment, 2021-2026 ($millions) (PT/INR Labs, Molecular, Professional POC, Professional Self; D-dimer)
      • Table Global Coagulation Test and Instrument Market by Region, 2021 (North America, Europe, Asia Pacific, RoW)
    • Lab-based Testing
      • Table Selected Lab-based Coagulation Innovations
      • Genetic Markers of Hypercoagulopathies
        • Table Related CMS Codes for Reimbursement National Limits, Molecular, 2020
        • Table Global Molecular - Thrombophilia SNP Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
        • Table Selected Molecular Coagulation Test Innovations
    • Leading Suppliers: Laboratory Systems
      • Table Top Coagulation Company Revenues, Laboratory-based - 2021 ($ millions) est
    • Decentralized Coagulation Testing - Professional Use
      • Decentralized Coagulation Testing - OTC
        • Table Selected POC Coagulation Test Innovations
      • Platelet Testing
        • Table Selected Platelet Activity Test Innovations
    • Leading Suppliers: POC Systems
      • Table Top Coagulation Company Revenues, POC - 2021 ($ millions) est
    • The Commercial Market for Coagulation Tests
      • Table Major Anticoagulants Uses and Tests
  • Microbiology and Virology
    • The Real Impact of Infections
      • Herpes and Alzheimer's Disease
      • Ebola and Cancer
      • HIV and Cancer
      • H pylori and Cancer
      • Bacteria and Parkinson's
    • Microbial Antibiotic Resistance - The Role of Clinical Tests
      • "Faster Identification: Where Are We?"
        • Table Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
    • Traditional Microbiology and Its Limits
    • The New Microbiology - Innovations
      • Liquid Based Microbiology and Automation Innovations
      • Post-Blood Culture Microbial ID
      • PCR and Other NAAT-Based Tests for Infectious Diseases
        • Table Selected Nucleic Acid Amplification Test and Other Molecular Companies in Microbiology
      • Microbiome-Related Microbiology Tests
        • Table Selected Microbiome-Based Tests
      • Next Generation Sequencing-Based Microbiology Approaches
        • Table Selected Companies Applying DNA/RNA Sequencing to Microbiology
      • Syndromic Testing
    • New Infectious Disease Threats
      • Table Selected Companies Marketing Products Addressing Emerging Infectious Disease Threats
      • Tickborne Diseases (TBDs)
      • Zika
      • Chagas
      • Dengue
      • Ebola
      • Chikungunya
      • Next Threats?
        • Table Country COVID-19 Test Volume, Average per Day (June-August 2021)
        • Table Total COVID-19 Test Volume by Country, Average Estimates June-August 2021 (Millions)
        • Table Estimated Market Distribution, COVID-19 Test Value, 2021
    • Microbiology Firms Acquisitions and Collaborations
    • Market Analysis
      • Table Global Microbiology Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
    • Market Analysis - Traditional Microbiology ID/AST
      • Table Global Microbiology ID/AST Market, 2021-2026 (in millions USD) (ID/AST Auto, ID/AST Panels, Blood Culture, Chromogenic Media, Rapid Microbiology; ID/AST Supplies)
      • Table Global ID/AST Testing Sales Distribution by Region, 2021 (North America, Europe, Asia Pacific, RoW)
      • Traditional ID/AST
        • Table Global ID/AST Testing, Distribution by Systems, 2021 (%) (Panel, Auto)
      • Blood Culture
        • Table Selected Advanced Techniques in Positive Blood Culture
      • Chromogenic Media
      • Rapid Tests Performed on Colonies from Culture Media
      • Supplies
    • Market Analysis - Microbiology Immunoassays
      • Improvements in Microbiology Immunoassays
        • Table Selected Infectious Disease Immunoassay Innovations
        • Table Global Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market by Pathogen, 2021 (in $ millions) (Hepatitis, HIV, STDs, TORCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Lyme disease, Other, COVID-19) est
        • Table Global Laboratory-Based Microbiology/Infectious Disease Immunoassay Market Distribution (by %) by Region, 2021 (North America, Europe, Asia Pacific, RoW)
      • Hepatitis Testing
      • Sepsis
      • HIV Immunoassay Testing
        • Table Selected HIV Assays
      • Sexually Transmitted Diseases (STDs)
      • ToRCH
      • Lyme Disease
      • Rapid Immunoassay Tests
        • Table Global Rapid Immunoassay Testing Market, Sales Distribution by Pathogen, 2021 (%) (Influenza, HIV, STD, Hepatitis, Malaria, C.Difficile, E.coli, H.pylori, Home Test/OTC, Others)
    • Market Analysis - Molecular Microbiology
      • Table Global Molecular Microbiology Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
      • Table Global Molecular Microbiology Market, by Pathogen/Disease Indication, 2021-2026 (in $ millions) (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria/TB, Others; Blood Bank Screening)
      • Lab Automation and Molecular Diagnostics
        • Table Selected Automated Molecular Test Instrument Platforms
      • Molecular Respiratory Infection Testing
      • The Respiratory Trio - Flu, Strep, RSV
        • Table Selected Molecular Point of Care Innovations in Microbiology
      • Molecular Testing for Sexually Transmitted Diseases
      • Molecular Hepatitis Testing
      • Molecular HIV Testing
        • Table Innovations in Molecular POC Diagnostics for HIV
      • Molecular Tests for Hospital-Acquired Infections (HAIs)
        • Table Frequency of the Most Common Nosocomial Infections
      • Assessing the Problem: Nosocomial Infection Statistics
      • Clostridium Difficile
      • MRSA
      • Molecular TB Testing
      • Limitations of Molecular Microbiology Testing
    • Mass Spectrometry
      • Table Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]
    • The Future Outlook for Microbiology
  • Blood Banking Services
    • Overview
      • The Current Status of Global Blood Collection
    • Global Blood Safety
      • Table Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV, Chagas, Malaria, HTLV I/II)
      • Table Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
      • Zika Virus
      • Blood and Component Collection
        • Table Blood Component Usage for Selected Conditions
        • Table Red Blood Cell and Platelet Use by Hospital Services (%)
      • COVID-19 Impact on Plasma Collection
      • Reevaluating Blood Transfusions
        • Table Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
    • Blood Typing and Grouping Market
      • Manual Blood Typing Methods
      • Automated Blood Typing and Screening Methods
      • Molecular Methods
      • Reducing Blood Typing Errors
        • Table Selected Blood Typing and Grouping Innovations
      • Size and Growth of Typing Markets
        • Table Global Blood Typing Market, 2021-2026 (Typing) (in $ millions)
      • Blood Typing Market by Geography
        • Table Global Blood Typing Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
    • Blood Testing Market
      • Table Selected Blood Testing Innovations
      • Preventing Bacterial Infections
      • Immunoassays
      • Nucleic Acid Testing (NAT)
      • Size and Growth of the Market
        • Table Global Blood Banking Diagnostics Market, 2021-2026 (Immunoassay Screen, NAT Screens) (in $ millions)
      • Blood Testing Market by Geography
        • Table Global Blood Testing Market by Geography, 2021 (%) (North America, Europe, Asia Pacific, RoW)
        • Table Global Blood Testing Market by Country, 2021 (%) (United States, Canada, Germany, United Kingdom, France, Japan, China, Latin America)
    • The Commercial Outlook for Blood Banking Testing
  • Histology and Cytology
    • Overview
    • Special Topics
      • Histology Automation
        • Table Selected Histology Lab Automation
        • Table Histology Information Technology Tools
      • Advanced Analysis Solutions
        • Table Selected Advanced Histology Techniques
      • HPV Goes Core Lab
        • Table Global HPV Test Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
        • Table Selected HPV Test Innovations
    • Market Analysis
      • Table Global Histology/Cytology Sales by Type, 2021-2026 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL; Digital Imaging, CTCs, Flow Cytometry)
      • Histology/Cytology
        • Table Global Histology/Cytology Sales Distribution by Region, 2021 (%) (North America, Europe, Asia Pacific, RoW)
        • Table Revenues of the Major Histology Companies, 2016-2020 ($ millions, estimated)
        • Table Selected Vendors of Traditional Histology Stains
        • Table Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2019
      • Immunohistochemistry and In Situ Hybridization
        • Table Selected In Situ Hybridization-based Tests
        • Table Selected IHC Test Innovations
      • Pharmacodiagnostic Histology
        • Table Major Pharmacodiagnostic Markers
        • Table Selected Pharmacodiagnostic Histology Tests
      • Digital Imaging and Computational Pathology
      • COVID-19 and Digital Pathology
        • Table Selected Digital Imaging Innovations
      • Circulating Tumor Cells
        • Table Selected Innovations in CTC Technology
      • Flow Cytometry
    • The Commercial Outlook for Histology and Cytology Tests
  • Company Profiles: The Top Tier
    • Abbott Diagnostics
      • Alere Acquisition Update and Point of Care
      • Core Lab
      • Hematology
      • Blood Banking
      • Coagulation
      • Infectious Diseases - Molecular
      • Diabetes
      • HIV Point of Care
      • i-STAT Business
      • Companion Testing
      • Liquid Biopsy
      • COVID-19
    • Agilent Technologies
      • Agilent in Genomics
      • Cytogenetic Analysis
      • Sequencing
      • CRISPR
      • Flow Cytometry
      • Companion Diagnostics - Dako
      • COVID-19
    • Beckman Coulter, Inc. / Danaher
      • Hematology
      • Hematology IT
      • Clinical Chemistry
      • Immunoassays
      • Coagulation
      • Microbiology
      • Clinical Information Technology
      • Flow Cytometry
      • Blood Banking
      • Beckman Coulter Life Sciences
      • Collaborations
      • COVID-19
    • Becton, Dickinson and Company (BD)
      • Cytology
      • Molecular Microbiology
      • Traditional Microbiology - ID/AST
      • Blood Culture
      • Hospital Acquired Infections
      • Connectivity
      • Blood Collection
      • Mass Spectrometry
      • Flow Cytometry
      • Licensing
      • COVID-19
    • bioMérieux Inc.
      • Traditional Microbiology
      • Blood Culture
      • Immunoassays
      • Mass Spectrometry
      • BioFire Diagnostics Business
      • Expansion
      • COVID-19
    • Bio-Rad Laboratories, Inc.
      • Quality Control
      • Blood Bank
      • Diabetes
      • Immunoassays
      • Autoimmune Testing
      • Liquid Biopsy
      • Microbiome
      • Droplet Digital PCR
      • Sequencing
      • COVID-19
    • Bruker Corporation
      • Acquisitions and Collaborations
      • Microbiology
      • Molecular PCR
      • COVID-19
    • Cepheid / Danaher
      • GeneXpert Xpress Line
      • High Burden Expansion
      • India
      • Tuberculosis
      • Microbiology
      • POC Testing
      • Cancer
      • COVID-19
    • Danaher Corporation
      • Acquisitions
    • DiaSorin S.p.A
      • Development Plan
      • Expansion
      • Immunoassays
      • Zika Testing
      • Molecular
      • Molecular Oncology
      • COVID-19
    • Grifols S.A.
      • Blood Transfusion Business
      • ABO Blood Typing
      • Molecular ABO Blood Typing
      • Immunoassays
      • Coagulation
      • Market Expansion
      • COVID-19
    • Hologic, Inc.
      • Acquisitions
      • PANTHER Molecular System
      • HIV Testing
      • Sexually Transmitted Infections
      • Infectious Diseases
      • Panther Fusion
      • Cytology
      • COVID-19
    • Instrumentation Laboratory (IL) / Werfen
      • Expansion
      • Coagulation
      • Acute Care
      • Information Technology
    • Leica Biosystems/Danaher
      • Digital Pathology
      • Stain Reagents
      • Lab Systems
      • Sample Handling
      • Circulating Tumor Cells (CTCs)
      • Artificial Intelligence
      • COVID-19
    • Ortho Clinical Diagnostics (Ortho)
      • Blood Bank
      • Core Lab / Immunoassays
      • Lab Automation
      • Connectivity
      • Expansion
      • COVID-19
    • PerkinElmer, Inc. (PE)
      • Diagnostics
      • Sequencing /Genomics
      • Liquid Biopsy
      • Histology
      • Prenatal Business
      • Lab Services
      • Mass Spectrometry
      • COVID-19
    • QIAGEN
      • Tuberculosis
      • Molecular Expansion
      • Precision Medicine / Companion Diagnostics
      • Molecular Microbiology
      • Prenatal Testing
      • Next Generation Sequencing
      • Sample Prep, Informatics
      • Digital PCR
      • Bioinformatics
      • Liquid Biopsy
      • Cervical Cancer
      • Transplant Medicine
      • Expansion
      • COVID-19
    • Quidel Corporation
      • The Alere Triage Business
      • Immunoassays
      • Rapid Immunoassays
      • The Solana Business
      • Molecular - Savanna
      • COVID-19
    • Radiometer A/S / Danaher
      • Critical Care
      • Immunoassays
      • HemoCue
      • Transcutaneous Monitoring
    • Roche Diagnostics
      • Hematology
      • Core Lab
      • Immunoassays
      • HIV
      • Molecular Expansion
      • Core Molecular
      • Digital PCR
      • Diabetes Care
      • Coagulation
      • cobas Liat System - POC
      • HPV
      • Blood Bank
      • Transplant Medicine
      • Cancer Companion Testing
      • Prenatal
      • Liquid Biopsy
      • IT in Anatomical Pathology
      • Information Technology
      • COVID-19
    • Siemens Healthineers (Siemens)
      • Core Lab
      • Lab Automation
      • Immunoassays
      • Hematology
      • Urinalysis
      • Molecular
      • Expansion to Support Molecular Diagnostics - Fast Track Diagnostics
      • Sequencing with Artificial Intelligence
      • Zika Virus Testing
      • Acute Care - POC
      • POC Connectivity
      • Business Expansion
      • COVID-19
    • Sysmex Corporation
      • Hematology
      • Coagulation
      • Urinalysis
      • Immunoassays
      • Lab Information System
      • Information Technology
      • Flow Cytometry
      • Precision Medicine / Companion Test Diagnostics
      • Liquid Biopsy
      • Exosomes
      • Oncology
      • Sysmex Inostics
      • Forging New Markets
      • COVID-19
    • Thermo Fisher Scientific Inc.
      • Immunoassays
      • Microbiology
      • Molecular Test Business
      • Next Generation Sequencing
      • qPCR
      • Oncology Companion Diagnostics
      • Liquid Biopsy
      • Zika Virus
      • Transplant Medicine
      • Microbiome
      • Forensics
      • Mass Spectrometry
      • Collaborations
      • Gene Editing and Cell Therapy
      • China
      • COVID-19
    • Ventana Medical Systems Inc. / Roche Tissue Diagnostics
      • Immunohistochemistry - IHC
      • Cervical Cancer Screening
      • Companion Diagnostics
    • Werfen
  • Company Profiles: The Second Tier
    • ARKRAY
      • Dry Chemistry / Immunoassays
      • Urinalysis
      • Diabetes
      • Molecular
    • BGI Genomics (formerly Beijing Genome Institute)
      • MGI Tech Co., Limited, China
      • Complete Genomics
      • Prenatal Testing
      • Test Services
      • Liquid Biopsy
      • Whole Genome Sequencing (WGS)
      • Collaborations
      • COVID-19
    • Dexcom
    • Diagnostica Stago S.A.S.
    • Eiken Chemical Co., Ltd
      • Product News
      • COVID-19
    • Exact Sciences
      • COVID-19
    • Fujirebio Diagnostics, Inc.
    • GenMark Diagnostics, Inc
      • COVID-19
    • Guardant Health, Inc.
    • Horiba Medical
    • Illumina
      • Sequencing
      • Advancing in the Clinical Market
      • Sequencing Data Analysis
      • Project Firefly
      • Transplant Medicine
      • Liquid Biopsy
      • Forensic Medicine
      • Prenatal Testing Business
      • Collaborations
      • China
      • COVID-19
    • LabCorp, Laboratory Corporation of America
      • Precision Medicine
      • Diagnostics Services
      • DTC Home Testing
      • Prenatal
      • Retail Services
      • Collaborations and Expansion
      • COVID-19
    • Luminex Corporation
      • Assay Development
      • VERIGENE Business
      • PCR
      • Flow Cytometry
      • Business Expansion
      • COVID-19
    • Masimo Corporation
    • A. Menarini Diagnostics
      • COVID-19
    • Meridian Bioscience, Inc.
      • Immunoassays
      • Molecular Tests
      • COVID-19
    • Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
      • Core Lab
      • Hematology
    • Myriad Genetics, Inc.
    • Nova Biomedical Corporation (Nova)
    • Philips (Royal Philips)
      • Histology
      • Cancer Genomics
      • Precision Medicine
      • Precision Medicine IT
      • Patient Monitoring
      • Point of Care
      • Wearable Self Monitor
    • Quest Diagnostics
      • Diagnostic Services
      • Oncology
      • Infectious Diseases
      • Prenatal and Women's Health
      • Retail / Consumer Health
      • Expansion
      • COVID-19
    • Randox Laboratories Ltd.
      • Clinical Chemistries
      • Controls
      • Evidence Series - Multistat Biochip Analyzers
      • Molecular
      • COVID-19
  • Company Profiles: Blood Bank Specialists
    • Cerus Corporation
      • COVID-19
    • Quotient Limited
      • COVID-19
  • Company Profiles: Core Lab and Other Companies
    • AB SCIEX Pte Ltd.
    • EKF Diagnostics Holdings Plc
      • COVID-19
    • ELITech Group S.A.S.
      • COVID-19
    • MedTest DX
      • COVID-19
    • Microsaic Systems plc
    • Nova Biomedical
    • Scienion AG
    • Sekisui Diagnostics LLC
      • COVID-19
    • Shimadzu Scientific Instruments
    • Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
      • COVID-19
    • Tecan Group
      • COVID-19
    • Tosoh Bioscience
      • COVID-19
    • Trinity Biotech Plc
      • COVID-19
  • Company Profiles: CTC & Liquid Biopsy Test Providers
    • Biocartis
      • COVID-19
    • Biocept, Inc.
      • COVID-19
    • Biodesix
      • COVID-19
    • Epic Sciences
    • Epigenomics AG
    • Foundation Medicine, Inc.
    • LungLife AI
    • Menarini-Silicon Biosystems
      • COVID-19
    • Natera
    • NeoGenomics
  • Company Profiles: Specialists
    • Ascensia Diabetes Care Holdings AG
    • Bigfoot Biomedical Inc.
    • Debiotech SA
      • COVID-19
    • Glooko Inc.
    • Insulet Corporation
    • Integrity Applications Inc.
    • LifeScan Inc.
    • Medtronic plc
    • Nemaura Medical Inc.
      • COVID-19
    • Verily Life Sciences LLC
      • COVID-19
  • Company Profiles: Hematology (Cell Analysis) and Coagulation Specialists
    • CellaVision AB
  • Company Profiles: Histopathology Specialists
    • Amoy Diagnostics Co. Ltd.
    • Applied Spectral Imaging Inc. (ASI)
    • BioGenex Laboratories, Inc.
    • BioView Ltd.
    • HTG Molecular Diagnostics
    • Leica Biosystems
      • COVID-19
    • MilliporeSigma (formerly EMD Millipore)
      • COVID-19
    • Visiopharm
  • Company Profiles: Immunoassay Specialists
    • Binding Site Group Ltd. (The)
      • COVID-19
    • Biohit Healthcare
    • Biomerica Inc.
      • COVID-19
    • Bio-Techne Corporation
      • COVID-19
    • Eurobio Scientific
      • COVID-19
    • EUROIMMUN AG
      • COVID-19
    • HOB Biotech
      • COVID-19
    • Immunodiagnostic Systems (IDS)
      • COVID-19
    • INOVA Diagnostics, Inc.
      • COVID-19
    • One Lambda, Inc
    • Response Biomedical Corp.
      • COVID-19
    • Theradig
      • COVID-19
    • VolitionRx Limited
      • COVID-19
  • Information Technology Specialists in In Vitro Diagnostics
    • Advaita Corp.
      • COVID-19
    • Cerner Corp.
    • Dell Technologies Inc.
    • Euformatics Oy
    • GenomOncology LLC
    • Google LLC
    • Intel Corporation
    • International Business Machines Corp. (IBM)
    • PierianDx
    • Rennova Health, Inc.
    • SOPHiA GENETICS SA
      • COVID-19
    • Sunquest Information Systems Inc.
      • COVID-19
    • WuXi NextCODE (now Genuity Science)
  • Company Profiles: Microbiology Specialists
    • Accelerate Diagnostics, Inc.
      • COVID-19
    • Advanced Biological Laboratories, S.A. (ABL)
      • COVID-19
    • altona Diagnostics
      • COVID-19
    • ArcDia International Oy Ltd.
      • COVID-19
    • BioFire Diagnostics, LLC. (Acquired by bioMérieux)
      • COVID-19
    • COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
      • COVID-19
    • Curetis
      • COVID-19
    • Genetic Analysis AS
      • COVID-19
    • Greiner Bio-One International GmbH
    • Hain Lifescience GmbH
      • COVID-19
    • Mast Group
      • COVID-19
    • Mobidiag
      • COVID-19
    • Q-linea AB
    • OpGen, Inc.
      • COVID-19
    • Seegene, Inc.
      • COVID-19
    • Specific Technologies
    • T2 Biosystems
      • COVID-19
  • Company Profiles: Molecular Test Specialists
    • Asuragen Inc.
      • COVID-19
    • Enzo Biochem Inc.
      • COVID-19
    • Exosome Diagnostics, Inc. (Bio-Techne)
      • COVID-19
    • Fluidigm Corporation
      • COVID-19
    • Genome Diagnostics BV (GenDx)
    • NanoString Technologies, Inc.
      • COVID-19
    • Oxford Nanopore Technologies Ltd
      • COVID-19
    • Pacific Biosciences of California, Inc. (PacBio)
      • COVID-19
    • Takara Bio Inc.
      • COVID-19
    • Vela Diagnostics
      • COVID-19
  • Company Profiles: Point of Care Test Specialists
    • Abaxis, Inc.
    • Abingdon Health Ltd.
      • COVID-19
    • binx Health
      • COVID-19
    • Biomeme, Inc.
      • COVID-19
    • Chembio Diagnostic Systems, Inc.
      • COVID-19
    • Diazyme
      • COVID-19
    • DNA Electronics Ltd (DNAe)
    • Fio Corporation
      • COVID-19
    • Genedrive plc (formerly Epistem Holdings)
      • COVID-19
    • NuGenerex Diagnostics (HDS)
    • Immunostics, Inc.
      • COVID-19
    • Loop Medical
    • MedMira, Inc.
      • COVID-19
    • OraSure Technologies, Inc.
      • COVID-19
    • PTS Diagnostics
      • COVID-19
    • QuantuMDx Group, Ltd.
      • COVID-19
    • Rheonix, Inc.
      • COVID-19
    • Veredus Laboratories Pte Ltd
      • COVID-19
  • Company Profiles: Prenatal Test Service Providers
    • Berry Genomics Co. ltd.
    • CooperGenomics (Division of CooperSurgical)
    • Eurofins LifeCodexx AG
    • Myriad Women's Health
    • INEX Innovate
      • COVID-19
    • Invitae
    • Oxford Gene Technology
    • Sequenom, Inc. (Integrated Genetics)
    • Yourgene Health
      • COVID-19
  • Company Profiles: Quality Control & Sample Pretreatment Specialists
    • 10x Genomics
    • Agena Bioscience, Inc.
      • COVID-19
    • Biotype Diagnostic GmbH
      • COVID-19
    • DxTerity Diagnostics Inc.
      • COVID-19
    • Horizon Discovery Group plc
    • IncellDx
    • LGC SeraCare Life Sciences, Inc.
      • COVID-19
    • PreAnalytiX GmbH
    • Precipio, Inc. (formerly Transgenomic)
      • COVID-19
    • Quanterix Corporation
      • COVID-19
    • Streck Inc.
  • Test Service Providers
    • 23andMe
    • Agendia BV
    • Ambry Genetics
      • COVID-19
    • ARUP Laboratories
      • COVID-19
    • Aspira Women's Health (formerly Vermillion Inc.)
    • BioReference Laboratories
      • COVID-19
    • Biotheranostics
    • BluePrint Genetics Oy
    • Boston Heart Diagnostics
    • CareDx, Inc.
    • Eurofins Genomics
      • COVID-19
    • Helomics Corporation
    • Mayo Clinic Laboratories
    • MDxHealth SA
    • OPKO Diagnostics
      • COVID-19
    • Sonic Healthcare
    • Veracyte, Inc.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook